ConductScience.org, home

Paper7031389

A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

Shepard CC. Lepr Rev, 1981. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation. Papers, record 7031389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7031389

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.
PubMed
Journal
Lepr Rev
PubMed
Year
1981
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2019-09-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shepard CCC C

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LeprosyMajor topic
Mycobacterium lepraeMajor topic
RifampinMajor topic
Animals
Clinical Trials as Topic
Drug Evaluation, Preclinical
Humans
Mice
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
21430881Leprosy therapy, past and present: can we hope to eliminate it?Indian J Dermatol2010https://conductscience.org/library/papers/21430881PubMed
19596891The diarylquinoline R207910 is bactericidal against Mycobacterium leprae in mice at low dose and administered intermittently.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19596891PubMed
18573938Powerful bactericidal activity of moxifloxacin in human leprosy.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18573938PubMed
8141581Clinical trial of sparfloxacin for lepromatous leprosy.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8141581PubMed
8031029Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8031029PubMed
7979302Clinical trial of fusidic acid for lepromatous leprosy.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7979302PubMed
7698121Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.Eur J Clin Microbiol Infect Dis1994https://conductscience.org/library/papers/7698121PubMed
3402581The incubation time of relapses after treatment of multibacillary leprosy with rifampicin containing regimens.Eur J Epidemiol1988https://conductscience.org/library/papers/3402581PubMed
1737148A clinical trial of minocycline in lepromatous leprosy.BMJ1992https://conductscience.org/library/papers/1737148PubMed
1539986Novel assay for screening rifamycin B-producing mutants.Appl Environ Microbiol1992https://conductscience.org/library/papers/1539986PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7031389

GET https://conductscience.org/api/papers/v1/7031389/authors